Determinants of clinical outcome in high grade serous ovarian cancer

被引：0
|
作者：
Bowtell, David D. L. [1 ]
Cown, Prue [1 ]
Etemadmoghadam, Dariush [1 ]
Alsop, Kathryn [1 ]
George, Joshy [1 ]
de Fazaio, Anna [2 ]
Mitchell, Gillian [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Westmead Inst Canc Reseach, Sydney, NSW, Australia
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-5082
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5082
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Certain fusion genes are associated with clinical outcomes in high grade serous ovarian cancer
    Newtson, Andreea Mihai
    Reyes, Henry D.
    Lyons, Yasmin A.
    Devor, Eric
    Goodheart, Michael Joseph
    Gonzalez-Bosquet, Jesus
    GYNECOLOGIC ONCOLOGY, 2020, 159 (02) : E12 - E12
  • [22] High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
    Lisio, Michael-Antony
    Fu, Lili
    Goyeneche, Alicia
    Gao, Zu-hua
    Telleria, Carlos
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (04)
  • [23] Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer
    Hillman, R. Tyler
    Chisholm, Gary B.
    Lu, Karen H.
    Futreal, P. Andrew
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (03): : 265 - 272
  • [24] B cells critical for outcome in high grade serous ovarian carcinoma
    Vledder, Annege
    Paijens, Sterre T.
    Loiero, Dominik
    Maagdenberg, Alexis
    Duiker, Evelien W.
    Bart, Joost
    Hendriks, Anne M.
    Jalving, Mathilde
    Werner, Naomi
    van Rooij, Nienke
    Plat, Annechien
    Wisman, G. Bea A.
    Yigit, Refika
    Roelofsen, Thijs
    Kruse, Arnold J.
    de Lange, Nastascha M.
    Koelzer, Viktor H.
    de Bruyn, Marco
    Nijman, Hans W.
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (12) : 2265 - 2276
  • [25] The Changing View of High-Grade Serous Ovarian Cancer
    Berns, Els M. J. J.
    Bowtell, David D.
    CANCER RESEARCH, 2012, 72 (11) : 2701 - 2704
  • [26] Overcoming Chemotherapy Resistance in High Grade Serous Ovarian Cancer
    Sundar, Raghav
    Tan, David
    Lei, Lim S.
    Chia, Whay-Kuang
    CURRENT CANCER THERAPY REVIEWS, 2016, 12 (01) : 23 - 36
  • [27] MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
    Baath, Maria
    Jonsson, Jenny-Maria
    Fremer, Sofia Westbom
    de la Fuente, Laura Martin
    Tran, Lena
    Malander, Susanne
    Kannisto, Paivi
    Masback, Anna
    Honeth, Gabriella
    Hedenfalk, Ingrid
    GENES, 2021, 12 (05)
  • [28] High-grade serous ovarian cancer: the clone wars
    Aleksander Salomon-Perzyński
    Magdalena Salomon-Perzyńska
    Bogdan Michalski
    Violetta Skrzypulec-Plinta
    Archives of Gynecology and Obstetrics, 2017, 295 : 569 - 576
  • [29] High-grade serous ovarian cancer: the clone wars
    Salomon-Perzynski, Aleksander
    Salomon-Perzynska, Magdalena
    Michalski, Bogdan
    Skrzypulec-Plinta, Violetta
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2017, 295 (03) : 569 - 576
  • [30] BRCA mutations in high grade serous ovarian cancer in Kazakhstan
    Kaidarova, Dilyara
    Bolatbekova, Raikhan
    Naumann, Robert
    Brown, Jubilee
    Kukubassov, Yerlan
    Goncharova, Tatyana
    Orazgaliyeva, Madina
    Aidarov, Askar
    Osikbayeva, Saniya
    Satanova, Alima
    Kaldybekov, Dauren
    Ismailov, Sanzhar
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A169 - A170
12345